Revolution Medicines, Inc. (RVMDW) Operating cash flow 2018–2025
Revolution Medicines, Inc. (RVMDW) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$897.7MFY2025 · since FY2018: $1.2M → -$897.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$897.7M | -61.0% |
| FY2024 | -$557.4M | -59.0% |
| FY2023 | -$350.6M | -56.2% |
| FY2022 | -$224.4M | -52.5% |
| FY2021 | -$147.2M | -47.1% |
| FY2020 | -$100.1M | -101.7% |
| FY2019 | -$49.6M | -4190.4% |
| FY2018 | $1.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More RVMDW financial trends
RVMDW RevenueRVMDW Net incomeRVMDW Net marginRVMDW Gross profitRVMDW Gross marginRVMDW Operating incomeRVMDW Operating marginRVMDW Free cash flowRVMDW Capital expendituresRVMDW Return on equityRVMDW Stock buybacksRVMDW Dividends paidRVMDW Total assetsRVMDW Total liabilitiesRVMDW Shareholders’ equityRVMDW overview →